Patheon gets bigger in softgels with Procaps alliance
January 24, 2012Manufacturing and Production Patheon, Procaps, manufacturing
Contract development and manufacturing organisation Patheon has stepped up its position in the market for pharmaceutical capsules with the signing …
Alnylam cuts workforce by a third
January 23, 2012Research and Development, Sales and Marketing Alnylam, Novartis, job cuts, rnai
Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …
MPs to criticise NHS reforms
January 23, 2012Sales and Marketing Clegg, Dorrell, NHS reform, health bill
Reform of the NHS is risking its financial stability and the care of the elderly, according to MPs. The concerns …
Carbogen Amcis buys French CRO
January 23, 2012Manufacturing and Production Carbogen Amcis, Creapharm Parenterals
Swiss contract manufacturing organisation Carbogen Amcis has acquired a contract manufacturer based in France – Creapharm Parenterals – to bolster …
Contract research news in brief
January 23, 2012Research and Development CoreLab Partners and Acurian, Quintiles, vivoPharma
Quintiles invests in new biomarket firm and sets up a new office in China, plus updates from vivoPharma, CoreLab Partners …
Merck pays $37m to settle Canadian Vioxx claims
January 23, 2012Sales and Marketing Canada, Merck, Vioxx
Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada. The settlement …
Genzyme lifted by EU approval of Fabrazyme facility
January 20, 2012Manufacturing and Production Boston, EMA, Fabrazyme, Genzyme
Sanofi subsidiary Genzyme moved a crucial step closer to resolving its long-standing manufacturing problems after the European Medicines Agency gave …
Payment changes of authority’s fees in France
January 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates, regulatory affairs
Changes are being made in the way fees are paid for regulatory submissions and procedures in France. Fees are no …
Novartis’ Signifor recommended in Europe
January 20, 2012Research and Development, Sales and Marketing CHMP, Cushing's disease, Novartis, Signifor
A European committee has recommended Novartis’ Signifor for the treatment of a rare, debilitating endocrine disorder. The European Committee for …
EMA to review safety of MS drug Gilenya
January 20, 2012Research and Development, Sales and Marketing CHMP, EMA, Novartis, gilenya
The European Medicines Agency has begun a review into the safety of Novartis’ multiple sclerosis drug Gilenya. This follows concerns …
British pharmacy to sell ‘smart pills’
January 20, 2012Sales and Marketing Lloyds pharmacy, Proteus Biomedical, smart pill
Proteus Biomedical has teamed up with Lloydspharmacy to sell Helius, a smart pill that tells a patient when to take …
AZ and BMS diabetes drug needs more data
January 20, 2012Research and Development, Sales and Marketing AstraZeneca, BMS, FDA approvals, diabetes
AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …
Novartis starts late-stage biosimilar trials for Amgen drugs
January 19, 2012Research and Development, Sales and Marketing Amgen, Neulasta, Neupogen, Novartis
Novartis has begun Phase III biosimilar trials to copycat two of Amgen’s neutropenia drugs. The studies, which are being undertaken …
Chief operating officer appointed to Clinigen’s services division
January 19, 2012Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton
Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …
Takeda to cut 2,800 jobs
January 19, 2012Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts
Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …
Astellas Pharma Europe appoints Mike Crooks to head up its UK operations
January 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks
Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …
Nurses come out against Health Bill
January 19, 2012Sales and Marketing NHS, RCN, health bill, reforms
The union representing nurses and midwives in the UK has formally come out against the government’s health reform Bill. The …
Bayer’s colorectal cancer drug increases survival
January 19, 2012Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib
Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …
Lucentis approved in China
January 18, 2012Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets
Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …
Lundbeck gets award for manufacturing excellence
January 18, 2012Manufacturing and Production Lundbeck, Shingo, manufacturing
Efforts by Lundbeck to boost the productivity of its manufacturing operations have borne fruit, with the company cutting costs by …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
